a combined strategy incorporating multi-omics profiling, systems biology, multi-scale metabolic modeling, machine learning (ML), and real-time monitoring, adaptive feeding-guided SFM formulation
First-pass extracted concept
machine learning
Aliases
ML
Evidence Snippets
Artificial intelligence (AI), including machine learning, deep learning, and generative models, has begun to tackle this problem
We also present a pragmatic framework for the rational application of state-of-the-art tools, including cell-free systems, synthetic microbial consortia, hybrid chemoenzymatic synthesis, and machine learning, to sustainably produce paclitaxel and other natural products.
By integrating advances in machine learning, nanocarriers, base editing, and adaptive trial designs
the synthetic biology platforms outline the integration of machine learning and high throughput screening for the development of effective and efficient pathways.
Recent advances in machine learning and gene regulatory network modeling enhance the predictive interpretation of transcription-translation relationships, especially under combined or fluctuating stress conditions.
Data-driven AAV engineering, integrating machine learning and high-throughput screening, has significantly accelerated the development of next-generation vectors.
Supporting Sources
Linked Claims
AI methods are being used with cell-free systems to predict experimental outcomes, design new proteins, and identify improved reaction conditions.
The paper presents a pragmatic framework for rational application of cell-free systems, synthetic microbial consortia, hybrid chemoenzymatic synthesis, and machine learning to sustainable paclitaxel and natural product production.
Machine learning and gene regulatory network modeling enhance predictive interpretation of transcription-translation relationships, especially under combined or fluctuating stress conditions.
Synthetic biology offers substantial opportunities for de novo paclitaxel production, especially after recent advances in elucidating its biosynthetic pathways.
Paclitaxel supply remains persistently challenging for sustainable production.
Integrating machine learning, nanocarriers, base editing, and adaptive trial designs provides a structured strategy to bridge the translational gap.
By integrating advances in machine learning, nanocarriers, base editing, and adaptive trial designs, this roadmap provides a structured strategy to bridge the translational gap.
A combined strategy using multi-omics profiling, systems biology, multi-scale metabolic modeling, machine learning, and real-time monitoring with adaptive feeding-guided formulation is proposed to address lengthy development phases and industrialization costs in serum-free media adoption for cultivated meat.
Synthetic biology platforms integrate machine learning and high throughput screening to develop effective and efficient pathways in cell-free systems.
the synthetic biology platforms outline the integration of machine learning and high throughput screening for the development of effective and efficient pathways.
Data-driven AAV engineering that integrates machine learning and high-throughput screening has significantly accelerated development of next-generation vectors.